Companies / Traws Pharma, Inc. / Activity
Activity — Traws Pharma, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common stock | $28.3K | +15K +25.06% | 77,103 0.51% of shares | low |
| Q4 2024 as of | Danske Bank A/S 13F manager | Exit | Common stock | $-41 | -7 -100.00% | 0 | low |
| Q3 2024 as of | Danske Bank A/S 13F manager | New | Common stock | $41 | +7 | 7 <0.01% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Trim | Common stock | $-13 | -15 -0.15% | 9,941 0.07% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common stock | $12 | +11 +10.78% | 113 <0.01% of shares | low |
| Q2 2026 as of | SG Americas Securities, LLC 13F manager | New | Common stock | $12 | +15K | 14,524 0.10% of shares | low |
| Q1 2026 as of | Northwestern Mutual Wealth Management Co 13F manager | New | Common stock | $4 | +2 | 2 <0.01% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | New | Common stock | $0 | +6 | 6 <0.01% of shares | low |